SELLAS Life Sciences Group, Inc.SLSEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company focused on developing innovative cancer immunotherapies for patients with unmet medical needs. Its core pipeline targets both hematological malignancies and solid tumors, with lead product candidates addressing indications like acute myeloid leukemia, primarily serving markets across North America.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Highbridge Capital Management, LLC | 9.90% | 13.3M | ▲ +3.40pp | 2024-11-08 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.